Unclaimed brand
Moving Forward: Addimmune Research Continues at AGT Addimmune is the HIV functional cure development project at American Gene Technologies (AGT). You can find information on this site about our quest to develop a gene and cell therapy that is capable of providing people living with HIV (PLHIV) with durable remission from HIV with a single…
Liking this brand profile? Share this page
Hex Code
Color name
RGB
HSL
CMYK
#942707
Totem Pole
148, 39, 7
14, 91, 30
0, 74, 95, 42
#E4B9B9
Cavern Pink
228, 185, 185
0, 44, 81
0, 19, 19, 11
#154554
Elephant
21, 69, 84
194, 60, 21
75, 18, 0, 67
Addimmune is a pioneering brand dedicated to ending the global HIV epidemic through gene and cell-based therapies. With a profound understanding of the human aspect of their work, and a strong commitment to respecting, recognizing and alleviating the suffering of those living with HIV, Addimmune is devoted to diversity, collaborative innovation, and unwavering determination. Their leadership team includes CEO Jeff Galvin, renowned for his extensive experience in business and entrepreneurial ventures, Chief Science Officer Dr.
Jeff Boyle, and Chief Financial Officer Nick Tressler, amongst others. Addimmune boasts a diverse and experienced team that includes medical professionals and visionary leaders in legal and operational capacities, all aiming to fulfill the promise to end the HIV epidemic. Harnessing gene and cell therapy, Addimmune aims to deliver a functional cure for HIV, and their efforts are driven by empathy, compassion, and an unwavering commitment to end the HIV epidemic
Company type
Privately Held
Year founded
2023
Company size
11-50 employees
